TY - JOUR
T1 - Prognostic value of the Duke Treadmill Score in asymptomatic women
AU - Gulati, Martha
AU - Arnsdorf, Morton F.
AU - Shaw, Leslee J.
AU - Pandey, Dilip K.
AU - Thisted, Ronald A.
AU - Lauderdale, Diane S.
AU - Wicklund, Roxanne H.
AU - Al-Hani, Arfan J.
AU - Black, Henry R.
N1 - Funding Information:
Dr. Gulati received funding support for this study from a grant from the Harry B. Graf Endowment Fund Career Development Award from the American College of Cardiology, Bethesda, Maryland. This study was also supported by grants from AstraZeneca, Wilmington, Delaware; DuPont Pharmaceuticals, Wilmington, Delaware; Irwin Foundation, Homewood, Illinois; Merck & Co., West Point, Pennsylvania; Pfizer/Pharmacia, New York, New York; and Siemans-Gammasonics, Hoffman Estates, Illinois. This study was initiated and supported by St. James Hospital and Health Centers, Chicago Heights, Illinois.
PY - 2005/8/1
Y1 - 2005/8/1
N2 - The Duke Treadmill Score (DTS) has been shown to predict mortality in women who have symptomatic heart disease, but its ability to do so in asymptomatic women is unknown, as is its comparative advantage to exercise capacity. We investigated whether a decreased DTS is associated with increased mortality in a prospective cohort of 5,636 asymptomatic women. A symptom-limited exercise treadmill test using Bruce's protocol was performed at baseline. DTS was calculated using exercise time, exercise-induced angina, and ST-segment depression. Exercise capacity was measured in METs. Deaths and cause of death were identified from 1992 to 2000. After adjusting for the Framingham Risk Score, the risk of death decreased by 9% for each unit increase in DTS and by 17% for every 1-MET increase (p <0.001). Those who had a DTS <5 (moderate or high risk) had hazard ratios for death and cardiac death that were 2.2 and 2.5 times greater, respectively, than did those who had a DTS <5 (low risk), after adjusting for Framingham Risk Score (p <0.001). Receiver-operating characteristic curves for the DTS model and the exercise capacity model were not significantly different. In conclusion, we have demonstrated that, although the DTS is an independent predictor of mortality and cardiac mortality in asymptomatic women, it does not appear to be a better predictor than exercise capacity alone. The role of ST-segment changes and symptoms with stress testing in asymptomatic women does not provide additional prognostic information.
AB - The Duke Treadmill Score (DTS) has been shown to predict mortality in women who have symptomatic heart disease, but its ability to do so in asymptomatic women is unknown, as is its comparative advantage to exercise capacity. We investigated whether a decreased DTS is associated with increased mortality in a prospective cohort of 5,636 asymptomatic women. A symptom-limited exercise treadmill test using Bruce's protocol was performed at baseline. DTS was calculated using exercise time, exercise-induced angina, and ST-segment depression. Exercise capacity was measured in METs. Deaths and cause of death were identified from 1992 to 2000. After adjusting for the Framingham Risk Score, the risk of death decreased by 9% for each unit increase in DTS and by 17% for every 1-MET increase (p <0.001). Those who had a DTS <5 (moderate or high risk) had hazard ratios for death and cardiac death that were 2.2 and 2.5 times greater, respectively, than did those who had a DTS <5 (low risk), after adjusting for Framingham Risk Score (p <0.001). Receiver-operating characteristic curves for the DTS model and the exercise capacity model were not significantly different. In conclusion, we have demonstrated that, although the DTS is an independent predictor of mortality and cardiac mortality in asymptomatic women, it does not appear to be a better predictor than exercise capacity alone. The role of ST-segment changes and symptoms with stress testing in asymptomatic women does not provide additional prognostic information.
UR - http://www.scopus.com/inward/record.url?scp=23044483980&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2005.03.078
DO - 10.1016/j.amjcard.2005.03.078
M3 - Article
C2 - 16054460
AN - SCOPUS:23044483980
SN - 0002-9149
VL - 96
SP - 369
EP - 375
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 3
ER -